Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,504,687
+$1,883,977 QoQ
Shares Held
810,462
-3.1% QoQ
Ownership
0.470%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ACAD ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,504,687 | 810,462 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,620,710 | 836,510 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $22,649,035 | 847,961 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $15,803,868 | 740,575 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,506,626 | 857,980 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $12,151,475 | 731,576 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,401,069 | 512,320 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,583,022 | 558,064 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,388,139 | 85,424 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,478,654 | 350,387 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $13,243,156 | 422,969 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,939,135 | 332,972 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $9,520,603 | 397,520 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,920,114 | 473,970 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $8,529,043 | 535,744 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,867,850 | 480,920 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,336,187 | 449,694 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,525,473 | 475,866 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,557,851 | 66,746 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,188,311 | 71,542 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,534,521 | 62,916 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $1,739,976 | 67,441 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $63,757,195 | 1,192,615 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $12,425,448 | 301,223 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,787,905 | 305,094 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,235,697 | 573,626 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||